prader-willi-syndrome | Media Room | PressRelease.com

Tagged prader-willi-syndrome

Press Release Dec 12, 2018

Levo Therapeutics Announces Initiation of the CARE-PWS Phase 3 Study of Intranasal Carbetocin for the Treatment of Prader-Willi Syndrome

Read More

Press Release Nov 8, 2018

World's Largest Newborn Screening Study for Four Rare Disorders Launches

Nonprofits co-fund feasibility study to test screening tool for 75,000 newborns for Angelman, Prader-Willi, Fragile X and Dup15q Syndromes

Press Release Jul 12, 2018

The Foundation for Prader-Willi Research and Zafgen Partner for PATH for PWS Natural History Study

Read More

Press Release Jun 21, 2018

Levo Therapeutics Announces Publication of Phase 2 Study Results and Planned Phase 3 Study of Intranasal Carbetocin for the Treatment of Prader-Willi Syndrome

Read More

Press Release May 17, 2018

Dr. Elisabeth Dykens Recieves 2018 NORD Rare Impact Award

Read More

Press Release Mar 8, 2018

FPWR Researchers Publish Latest Results

Read More

Press Release Jan 19, 2018

Foundation for Prader-Willi Research Announces Hire of Chief Executive Officer

FPWR Board of Directors Hires John Walter to Lead Organization

First
Prev

1

Next
Last